Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Venous Thromboembolism × Enoxaparin × Clear all

Phase

Phase 3 4 Phase NA 2 Phase 2 2 Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Classical hematology 1

Conditions

Venous Thromboembolism 1 Thrombosis 1 Thromboembolism 1 Thrombocytopenia 1 Sarcoma 1 Pancreatic Neoplasms 1 Hemorrhage 1 Hematoma 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Carcinoma, Hepatocellular 1 Bone Neoplasms 1

Interventions

apixaban 2 Aspirin 2 sotorasib 1 Rosuvastatin Calcium 1 Rivaroxaban 1 Enoxaparin 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation

Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡